Effects of rhG-CSF on neutrophil functions and survival in sepsis induced diabetic rats

Endocrine Research

Volumn 24, Issue 2, 1998, Pages 141-157

  Cantürk, Zeynep ^a,c   Cantürk, Nuh Zafer ^b   Önen, Fatoş ^a  

^a CUMHURIYET UNIVERSITY   (Turkey)

^b KOCAELI UNIVERSITY   (Turkey)

^c Canan Sk Asim Bey Ap   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTRIAXONE; KETAMINE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; STREPTOZOCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL INFECTION; CECOSTOMY; CELL ADHESION; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG EFFECT; DRUG SCREENING; GLUCOSE BLOOD LEVEL; IMMUNE DEFICIENCY; INTERMETHOD COMPARISON; LYMPHOCYTOPENIA; MORBIDITY; NEUTROPENIA; NEUTROPHIL; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; RAT; SEPSIS; STREPTOZOCIN DIABETES; SUBCUTANEOUS DRUG ADMINISTRATION; SURVIVAL RATE;

EID: 0031721456     PISSN: 07435800     EISSN: None     Source Type: Journal    
DOI: 10.1080/07435809809135524     Document Type: Article

References (40)

1. th ed., Lea&Febiger, Pennsylvania. pp.868-882.
2. Larkin JG, Frier BM, Ireland JT. 1985 Diabetes mellitus and infection. Postgraduate Med J 61:233-237.
3. Gleckman RA, Czachor JS. 1989 Managing diabetes-related infections in elderly. Geriatrics 44:37-46.
4. Reyfield EJ, Ault MJ, Keusch GT, Brothers MJ, Nechemias C, Smith H. 1982 Infections and diabetes: The case for glucose control. Am J Med 72:439-450.
5. Bagdade JD, Stewart M, Walters E. 1978 Impaired granulocyte adherence: a reversible defect in host defense in patients with poorly controlled diabetes. Diabetes 27:677-681.
6. Sato N, Shimizu H. 1993 Granulocyte-colony stimulating factor improves an impaired bactericidal function in neutrophils from STZ-induced diabetic rats. Diabetes Care 42:470-473.
7. Masuda M, Murakami T, Egawa H, Murata K. 1990 Decreased fludity of polymorphonuclear leukocyte membrane in streptozotocin induced diabetic rats. Diabetes 39:466-470.
8. Wilson RM. 1986 Neutrophil function in diabetes. Diabetic Med 3:509-512.
9. Mowat AG, Baum J. 1971 Chemotaxix of polymorphonuclear leukocytes from patients with diabetes mellitus. N Eng J Med 284: 621-627.
10. Valerius NH, Eff C, Hnasen NE, Karle H, Nerup J, Soeberg B, Sorensen SF. 1982 Neutrophil and lymphocyte function in patients with diabetes mellitus. Acta Med Scand 211:463-467.
11. Sato N, Shimuzu H, Shimomura Y, Uehara Y, Takahshi M, Kobayashi I. 1992 Reduced ability of neutrophils to produce active oxygen species in strepzotocin-induced diabetic rats. Exp Clin Endocrinol 9:31-33.
12. Kitagawa S, Yuo A, Souza LM, Saito M, Miura Y, Takaku F. 1987 Recombinant human granulocyte colony-stimulating factor enhances Superoxide release in human granulocytes stimulated by the chemotactic peptide. Biochem Biophys Res Comm 144:1143-1146.
13. Wichterman KA, Baue AE, Chaudry IH. 1980 Sepsis and septic shock: a review of laboratory models and a proposal. J Surg Res 29:189-201.
14. Brandt L. 1965 Adhesiveness to glass and phagocytic activity of neutrophilic leukocytes in myeloproliferative diseases. Scand J Haematol 2: 126-129.
15. Penny R, Galton DA, Scott JT, Eisen V. 1966 Studies on neutrophil function I: Physiological and pharmacological aspects. Br J Heaematol 12: 623-632.
16. Cutler CW, Eke P, Arnold RR, Van Dyke TE. 1991 Defective neutrophil function in an insulin dpendent diabetes mellitus patient. J Peridontol 2(6): 394-401.
17. Manouchehr-Pour M, Spagnuolo P, Rodman H, Bissada N. 1981 Impaired neutrophil chemotaxis in diabetic patients with severe periodonitis. J Dent Res 60:729-733.
18. Golub L, Nicoll G, Iacono V, Ramamurthy N. 1982 in vivo crevicular leukocyte response to a chemotactic challenge: Inhibition by experimental diabetes. Infect Immun 37:1013-1017.
19. th ed., Appleton&Lange; Lebanon. pp: 141-145.
20. Toda H, Murata A, Matssura N, Uda K, Oka Y, Tanaka N, Mori T. 1993 Therapeutic efficacy of granulocyte colony stimulating factor against rat cecal ligation and puncture model. Stem Cell 11: 228-234.
21. Daifuku R, Anderson , Morstn G. 1993 Recombinant methionyl human granulocyte colony-stimulating factor for the prevention and treatment of non-neutropenic infectious diseases. J of An Chemotherapy 32(Supply:A): 91-97.
22. Marhoffer W, Stein M, Masser E, Federlin K. 1992 Impairment of polymorphonuclear leukocyte function and metabolic control of diabetes. Diabetes Care 15:256-260.
23. Alexiewicz JM, Kumar D, Smogorzewski M, Klin M, Massry SG. 1995 Polymorphonuclear Leukocytes in non-insulin -dependent diabetes mellitus: Abnormalities in metabolism and function. Ann Intern Med 123:919-924.
24. Davidson J, Sowden JM, Fletcher J. 1984 Defective phagocytosis in insulin controlled diabetics: evidence for a reaction between glucose and opsonizing proteins . J Clin Pathol 37:783-790.
25. Bybee JD, Rogers DE. 1964 The phagocytic activity of polymorphonuclear leukocytes obtained from patients with diabetes mellitus. J Lab Clin Med 64: 1-13.
26. Drachman RH, Root RK, Wood WB. 1966 Studies on the effect of experimental nonketotic diabetes mellitus on antibactericidal defense : Demonstration of a defect in phagocytosis. J Exp Med 124: 227-240.
27. Esman V. 1961 The glucogen content of leukocytes from diabetic and nondiabetic patients. Scand J Clin Lab Invest 13: 134-137.
28. McColl CE, Caves J, Cooper R. 1971 Functional characteristic of human toxic neutrophils. J Inf Dis 124:68-75.
29. Solberg CO. 1972 Neutrophil granulocyte function in bacterial infections. Lancet, 7:727-730.
30. Stickle JE, Tvedten HW, Schall WD, Smith CW. 1986 Adherence of neutrophiis from dogs with diabetes mellitus. Am J Vet Res 47:541-543.
31. Blatmer KS, Mahaffey EA. 1984 Neutrophil adherence and movement in poorly and well controlled diabetic dogs. Am J Vet Res 45(8): 1498-1500.
32. Bagdade JD, Walters E. 1980 Impaired granulocyte adherence in mildly diabetic patients: effects of tolazamide treatment. Diabetes 29: 309-311.
33. Andersen B, Goldsmith GH, Spagnuolo PJ. 1980 Neutrophil adesive dysfunction in diabetes mellitus: The role of cellular plasma factors. J Lab Clin Med 111: 275-285.
34. Cairo MS, Rucker R, Bennetts GA, Hicks D, Worcester C, Amile R, Johnson S, Katz J. 1984 improved survival of newborns receiving leukocyte transfusion for sepsis. Pediatrics 74: 887-893.
35. Rockow EC, Asciz ME. 1993 Mechanisms and management of septic shock: Crit Care Clin 9: 219-237.
36. th ed. Churchill Livingstone, New York, pp. 690-705.
37. Iguchi K, Inoue S, Kumar A. 1991 Effect of recombinant human granulocyte colony stimulating factor administration in normal and experimentally infected newborn rats. Exp Hematol 19: 352-358.
38. Silver GM, O'Reilly M, Mooney DP I . 1989 The beneficial effect of granulocyte colony-stimulating factor (G-CSF) in combination with gentamicin on survival following Pseudomonas burn wound infection. Surgery 106: 452-455.
39. Lindemann A, Herrmann F, Oster W, Haffner G, Meyenburg W, Souza LM, Mertelsmann R. 1989 Hematologic effects of recombinant human granulocyte colon-stimulating factor in patients with malignancy. Blood 74(8): 2644-2651.
40. Roilides E, Walsh TJJ, Pizzo PA, Rubin M. 1991 Granulocyte colony stimulating factor enhances the phagocytic and bactericidal activity of normal and defective human neutrophils. J Inf Dis 163: 579-583.